# Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation

> **NCT04195256** · PHASE2,PHASE3 · RECRUITING · sponsor: **Naveen Poonai** · enrollment: 400 (estimated)

## Conditions studied

- Fracture
- Dislocation

## Interventions

- **DRUG:** IN Ketodex (D4K2)
- **DRUG:** IN Ketodex (D3K3)
- **DRUG:** IN Ketodex (D2K4)
- **DRUG:** IV Ketamine

## Key facts

- **NCT ID:** NCT04195256
- **Lead sponsor:** Naveen Poonai
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-03-11
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04195256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04195256, "Intranasal Dexmedetomidine Plus Ketamine for Procedural Sedation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04195256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*